Breast Cancer Screening in High-Risk Women: Is MRI Alone Enough?

Carolina Rossi Saccarelli^{1

2}, Almir G V Bitencourt^{1

3}, Elizabeth A Morris¹

Affiliations

¹ Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY.
² Department of Radiology, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
³ Department of Imaging, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.

Editorial

Carolina Rossi Saccarelli et al. J Natl Cancer Inst. 2020.

. 2020 Feb 1;112(2):121-122.

doi: 10.1093/jnci/djz130.

Carolina Rossi Saccarelli^{1

2}, Almir G V Bitencourt^{1

3}, Elizabeth A Morris¹

¹ Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY.
² Department of Radiology, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
³ Department of Imaging, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.

No abstract available

Comment on

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Chiarelli AM, Blackmore KM, Muradali D, Done SJ, Majpruz V, Weerasinghe A, Mirea L, Eisen A, Rabeneck L, Warner E. Chiarelli AM, et al. J Natl Cancer Inst. 2020 Feb 1;112(2):136-144. doi: 10.1093/jnci/djz079. J Natl Cancer Inst. 2020. PMID: 31233143 Free PMC article.

1. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. Obstet Gynecol Surv. 2007;62(7):458–460. - PubMed
1. National Comprehensive Cancer Network Guidelines. Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 3; 2019. Available from: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed June 12, 2019.
1. Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 2012;345(2):e5660–e5615. - PMC - PubMed
1. Chiarelli AM, Blackmore KM, Muradali D, et al. Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program. J Natl Cancer Inst. In press. - PMC - PubMed
1. Riedl CC, Luft N, Bernhart C, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33(10):1128–1135. - PMC - PubMed